Current:Home > ScamsIneffective ingredient could make Dayquil, Sudafed and others disappear from store shelves -ProgressCapital
Ineffective ingredient could make Dayquil, Sudafed and others disappear from store shelves
View
Date:2025-04-14 17:05:36
Pharmacies could pull common over-the-counter cold medications, including Dayquil, Sudafed and Theraflu, from store shelves after Food and Drug Administration experts determined one of the drugs' main ingredient doesn't work.
That could leave consumers scrambling to find alternative treatments for relief from nasal congestion and drugmakers hurrying to devise new drug formulations.
Drugs like Sudafed, made by pharmaceutical company Johnson & Johnson, are part of a roughly $2.2 billion market for oral decongestants. Products with formulations that contain phenylephrine, the drug FDA experts deemed ineffective, make up about four-fifths of that market.
"Unintended consequences"?
The Consumer Healthcare Products Association (CPHA) maintains that phenylephrine is effective and that the FDA's guidance could have significant "negative unintended consequences." Pulling drugs like Sudafed from store shelves would make it harder for consumers to treat mild illnesses, according to the industry trade group.
Removing popular over-the-counter medications from the market would force some people "to find time to seek help from a pharmacist, doctor or clinic for an oral decongestant for a minor ailment they could otherwise self-treat," the group said in a statement before the determination was made.
"Additionally, some consumers indicate they might delay or forgo treatment, which could lead to worsened clinical outcomes such as progression to acute sinusitis and increased demand for doctor and clinic visits over time," CPHA said.
Which drugs contain phenylephrine?
Phenylephrine is found in these and other OTC remedies for stuffy noses:
- Mucinex Sinus-Max
- Robitussin Peak Cold Nighttime Nasal Relief
- Sudafed PE Sinus Congestion
- Theraflu
- Vicks DayQuil and NyQuil Severe Cold & Flu
Phenylephrine is also found in other types of products, such as hemorrhoid creams, but was only deemed ineffective as an ingredient in oral form.
How big is the market for these drugs?
All told, decongestants with phenylephrine account for roughly $1.8 billion in annual sales, according to an FDA report.
Drugmakers also market a separate class of nasal decongestants containing pseudoephedrine (PSE). In 2006, OTC medications containing PSE were moved behind the pharmacy counter because of concerns they could be used to make illicit methamphetamines, which is when formulations with phenylephrine became more popular.
In 2022, stores sold roughly 242 million bottles or packages of OTC cold and allergy oral medications containing phenylephrine, according to the FDA. By comparison, stores that same year sold an estimated 51 million units of PSE, representing $542 million in sales in 2022.
"Sales of products containing PE, which amounted to only a small percentage of the market prior to 2006, have risen and displaced products containing PSE as an OTC decongestant, although sales of PSE, while smaller, remain," the FDA concluded.
The federal agency also acknowledged the potential "negative" impact that pulling oral PE products from shelves could have on consumers.
- In:
- FDA
veryGood! (6979)
Related
- Small twin
- Minnesota man awaiting trial in teen’s 1972 slaying is found dead in Illinois cell
- St. Louis wrecking crew knocks wall into transmission tower during demolition; brief explosion
- Sofía Vergara and Joe Manganiello Settle Divorce After 6 Months
- Olympic men's basketball bracket: Results of the 5x5 tournament
- Minnesota might be on the verge of a normal legislative session after a momentous 2023
- Nearly 200 abused corpses were found at a funeral home. Why did it take authorities years to act?
- What is Wagyu? The beef has a 'unique, meltaway texture' but comes with a heavy price tag
- Connie Chiume, Black Panther Actress, Dead at 72: Lupita Nyong'o and More Pay Tribute
- For San Francisco 49ers coach Johnny Holland, Super Bowl LVIII isn't his biggest challenge
Ranking
- Michigan lawmaker who was arrested in June loses reelection bid in Republican primary
- $700M man Shohei Ohtani is talk of Dodgers spring training: 'Can't wait to watch him play'
- Toby Keith wrote all kinds of country songs. His legacy might be post-9/11 American anger
- Stage adaptation of Prince's Purple Rain to debut in Minneapolis next year
- Tony Hawk drops in on Paris skateboarding and pushes for more styles of sport in LA 2028
- Biden disputes special counsel findings, insists his memory is fine
- When the voice on the other end of the phone isn't real: FCC bans robocalls made by AI
- Ed Dwight was to be the first Black astronaut. At 90, he’s finally getting his due
Recommendation
Your Wedding Guests Will Thank You if You Get Married at These All-Inclusive Resorts
Verizon teases upcoming Beyoncé Super Bowl commercial: What to know
These Are the Madewell Deals I'm Shopping This Weekend & They Start at $9.97
Iceland volcano at it again with a third eruption in as many months
Meet 11-year-old skateboarder Zheng Haohao, the youngest Olympian competing in Paris
5 key takeaways from the Supreme Court arguments over Trump's 2024 ballot eligibility
Usher reveals the most 'personal' song on new album: 'Oh, I'm ruined'
Elon Musk’s Neuralink moves legal home to Nevada after Delaware judge invalidates his Tesla pay deal